Cite
MLA Citation
A Gonzalez-Duarte et al.. “P.024 Long-term use of patisiran in patients with hereditary transthyretin amyloidosis (hATTR): 12 month efficacy & safety data from a global open label extension (OLE) study.” Canadian journal of neurological sciences, vol. 46, n.d., p. S20. http://access.bl.uk/ark:/81055/vdc_100101981375.0x000033